CA Patent
CA2854093A1 — 3,5-disubstituted alkynylbenzene compound and salt thereof
Assigned to Taiho Pharmaceutical Co Ltd · Expires 2013-07-25 · 13y expired
What this patent protects
The present invention provides a compound represented by general formula (I) or a salt thereof. (In the formula, R1, X1, X2, Y, and Z are as defined in the description.)
USPTO Abstract
The present invention provides a compound represented by general formula (I) or a salt thereof. (In the formula, R1, X1, X2, Y, and Z are as defined in the description.)
Drugs covered by this patent
- Lytgobi (futibatinib) · Taiho Oncology
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.